2 stories mentioning TXGUpdated 28d ago
Every FINWIRES story that references TXG, newest first.
10x Genomics (TXG) has an average rating of overweight and mean price target of $25.77, according to analysts polled by FactSet.Price: $43.00, Change: $+0.27, Percent Change: +0.63%
Serge Saxonov, Director, Chief Executive Officer, on June 22, 2026, sold 30,000 shares in 10x Genomics (TXG) for $1,033,269. Following the Form 4 filing with the SEC, Saxonov has control over a total of 1,393,301 Class A common shares of the company, with 1,108,380 shares held directly and 284,921 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1770787/000161071726000293/xslF345X05/form4.xml
